Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bellus Health Inc. (BLU : NSDQ)
 
 • Company Description   
BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.

Number of Employees: 32

 
 • Price / Volume Information   
Yesterday's Closing Price: $8.49 Daily Weekly Monthly
20 Day Moving Average: 1,073,196 shares
Shares Outstanding: 106.75 (millions)
Market Capitalization: $906.29 (millions)
Beta: 0.19
52 Week High: $9.84
52 Week Low: $2.60
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 4.69% 17.91%
12 Week 40.56% 54.54%
Year To Date 5.47% 28.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
275 ARMAND-FRAPPIER BLVD.
-
LAVAL,A8 H7V 4A7
CAN
ph: 45-0680-4500
fax: 45-0680-4501
ir@bellushealth.com http://www.bellushealth.com
 
 • General Corporate Information   
Officers
Roberto Bellini - Chief Executive Officer and President
Francesco Bellini - Chairman
Ramzi Benamar - Chief Financial Officer
Francois Desjardins - Senior Vice President
Tony Matzouranis - Senior Vice President

Peer Information
Bellus Health Inc. (CORR.)
Bellus Health Inc. (RSPI)
Bellus Health Inc. (CGXP)
Bellus Health Inc. (BGEN)
Bellus Health Inc. (GTBP)
Bellus Health Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 07987C204
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 106.75
Most Recent Split Date: 8.00 (0.28:1)
Beta: 0.19
Market Capitalization: $906.29 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.68 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.23
Price/Cash Flow: -
Price / Sales: 56,643.15
EPS Growth
vs. Year Ago Period: 35.00%
vs. Previous Quarter: 27.78%
Sales Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: 0.00%
ROE
03/31/22 - -35.61
12/31/21 - -44.68
09/30/21 - -51.92
ROA
03/31/22 - -32.97
12/31/21 - -41.35
09/30/21 - -48.05
Current Ratio
03/31/22 - 15.33
12/31/21 - 15.23
09/30/21 - 3.42
Quick Ratio
03/31/22 - 15.33
12/31/21 - 15.23
09/30/21 - 3.42
Operating Margin
03/31/22 - -436,406.25
12/31/21 - -445,149.94
09/30/21 - -399,712.47
Net Margin
03/31/22 - -436,406.25
12/31/21 - -445,149.94
09/30/21 - -399,712.47
Pre-Tax Margin
03/31/22 - -437,493.75
12/31/21 - -446,393.69
09/30/21 - -399,712.47
Book Value
03/31/22 - 2.62
12/31/21 - 2.74
09/30/21 - 1.22
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©